An intravitreal implant (OTX-TKI) containing the tyrosine kinase inhibitor axitinib (Inlyta) was well tolerated and significantly reduced injection frequency by nearly 90% in patients with wet ...

Using its gene therapy-based approach, GenSight Biologics’ product candidates are designed to be administered in a single ...

A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, ...

“These are devastating diseases with limited treatment options,” said Curt Breneman, Ph.D., dean of Rensselaer’s School of ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the annual meeting of the American ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

Staff and patients from Bridlington Hospital’s Eye Clinic have celebrated 10 years of treating patients across the East Coast ...

Intravitreal injections of anti-VEGF agents have become an important tool in the management of some of the most common retinal and choroidal neovascular diseases. Adverse effects are uncommon ...

Recent ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieved All Primary and Secondary Outcomes -- Positive Topline Results ...